Mbx Biosciences Common Stock Market Value
| MBX Stock | 28.24 1.07 3.65% |
| Symbol | MBX |
MBX Biosciences Common Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MBX Biosciences. If investors know MBX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MBX Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MBX Biosciences Common is measured differently than its book value, which is the value of MBX that is recorded on the company's balance sheet. Investors also form their own opinion of MBX Biosciences' value that differs from its market value or its book value, called intrinsic value, which is MBX Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MBX Biosciences' market value can be influenced by many factors that don't directly affect MBX Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MBX Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if MBX Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MBX Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MBX Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MBX Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MBX Biosciences.
| 12/07/2025 |
| 01/06/2026 |
If you would invest 0.00 in MBX Biosciences on December 7, 2025 and sell it all today you would earn a total of 0.00 from holding MBX Biosciences Common or generate 0.0% return on investment in MBX Biosciences over 30 days. MBX Biosciences is related to or competes with MeiraGTx Holdings, Replimune, ArriVent BioPharma, Ginkgo Bioworks, Iovance Biotherapeutics, MoonLake Immunotherapeuti, and Astria Therapeutics. MBX Biosciences is entity of United States More
MBX Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MBX Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MBX Biosciences Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.49 | |||
| Information Ratio | 0.1514 | |||
| Maximum Drawdown | 25.38 | |||
| Value At Risk | (6.76) | |||
| Potential Upside | 9.71 |
MBX Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MBX Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MBX Biosciences' standard deviation. In reality, there are many statistical measures that can use MBX Biosciences historical prices to predict the future MBX Biosciences' volatility.| Risk Adjusted Performance | 0.1296 | |||
| Jensen Alpha | 0.7938 | |||
| Total Risk Alpha | 0.3394 | |||
| Sortino Ratio | 0.1787 | |||
| Treynor Ratio | 0.7896 |
MBX Biosciences Common Backtested Returns
MBX Biosciences is not too volatile given 3 months investment horizon. MBX Biosciences Common has Sharpe Ratio of 0.21, which conveys that the company had a 0.21 % return per unit of standard deviation over the last 3 months. We have analyzed twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.15% are justified by taking the suggested risk. Use MBX Biosciences Common mean deviation of 4.09, and Downside Deviation of 4.49 to evaluate company specific risk that cannot be diversified away. MBX Biosciences holds a performance score of 16 on a scale of zero to a hundred. The firm secures a Beta (Market Risk) of 1.11, which conveys a somewhat significant risk relative to the market. MBX Biosciences returns are very sensitive to returns on the market. As the market goes up or down, MBX Biosciences is expected to follow. Use MBX Biosciences Common semi variance, as well as the relationship between the rate of daily change and relative strength index , to analyze future returns on MBX Biosciences Common.
Auto-correlation | 0.28 |
Poor predictability
MBX Biosciences Common has poor predictability. Overlapping area represents the amount of predictability between MBX Biosciences time series from 7th of December 2025 to 22nd of December 2025 and 22nd of December 2025 to 6th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MBX Biosciences Common price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current MBX Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 2.78 |
MBX Biosciences Common lagged returns against current returns
Autocorrelation, which is MBX Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MBX Biosciences' stock expected returns. We can calculate the autocorrelation of MBX Biosciences returns to help us make a trade decision. For example, suppose you find that MBX Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MBX Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MBX Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MBX Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MBX Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
MBX Biosciences Lagged Returns
When evaluating MBX Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MBX Biosciences stock have on its future price. MBX Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MBX Biosciences autocorrelation shows the relationship between MBX Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in MBX Biosciences Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.